Veracyte, Inc.
VCYT
Peringkat dalam Saham
#4238
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Harga Saham
$45.79
Kapitalisasi Pasar
$3.68B
Perubahan (1 hari)
-0.92%
Perubahan (1 tahun)
31.78%
Negara
US
Perdagangan Veracyte, Inc. (VCYT)
Kategori
Healthcare
Riwayat harga saham Veracyte, Inc. (VCYT)
Harga penutupan tertinggi: $44.59 pada 2026-10-01
Harga penutupan terendah: $12.82 pada 2013-10-01
Harga penutupan terendah: $12.82 pada 2013-10-01
Riwayat harga saham Veracyte, Inc. dari 2013 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | -2.87% |
| 2025 | 3.85% |
| 2024 | 55.02% |
| 2023 | 1.26% |
| 2022 | -33.63% |
| 2021 | -25.42% |
| 2020 | 88.25% |
| 2019 | 137.21% |
| 2018 | 87.23% |
| 2017 | -13.42% |
| 2016 | 5.54% |
| 2015 | -8.13% |
| 2014 | -43.76% |
| 2013 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $687.03 | 21.13% |
US
|
|
| $233.96 | 7.27% |
US
|
|
| $399.36 | 112.40% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $175.98 | 20.64% |
US
|
